Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1590 |
|---|---|
| Identifier | NCT04835506 |
| Trial Title | Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | Beth Israel Deaconess Medical Center |
|---|---|
| City | New Haven |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2021-11-01 |
|---|---|
| Primary Completion Date | 2026-09 |
| Completion Date | 2026-09 |